wuxiapptec

WuXi AppTec is a global pharmaceutical and life sciences company that provides integrated, end-to-end R&D and manufacturing services through its CRDMO (Contract Research, Development and Manufacturing Organization) platform. By combining scientific expertise with global infrastructure across Asia, Europe, and North America, the company enables partners to accelerate the drug development journey from early discovery and preclinical testing to clinical development and commercial manufacturing. Its platform supports a wide range of modalities, helping pharmaceutical companies, research institutions, and entrepreneurs transform scientific discoveries into real-world therapies while maintaining high standards for intellectual property protection and regulatory compliance.

The company's services are critical to customers in over 30 countries, assisting them in improving R&D productivity and reducing costs to bring breakthrough treatments to patients faster. WuXi AppTec facilitates innovation by linking startups, investors, and industry leaders through its expansive ecosystem. With decades of experience, the company has played a role in the development and approval of numerous therapies, including targeted treatments for cancer and other complex diseases. Committed to sustainability and ethical business practices, WuXi AppTec operates with the vision that every drug can be made and every disease can be treated, supporting a global community of innovators dedicated to advancing healthcare outcomes.